GOBBI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 2.285
AS - Asia 1.567
EU - Europa 1.244
SA - Sud America 154
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 8
Totale 5.413
Nazione #
US - Stati Uniti d'America 2.220
CN - Cina 772
SG - Singapore 352
IE - Irlanda 276
FI - Finlandia 163
HK - Hong Kong 163
UA - Ucraina 149
RU - Federazione Russa 147
DE - Germania 133
VN - Vietnam 125
BR - Brasile 109
IT - Italia 90
SE - Svezia 81
GB - Regno Unito 69
FR - Francia 61
ZA - Sudafrica 59
IN - India 44
CA - Canada 30
AR - Argentina 20
BD - Bangladesh 16
BE - Belgio 14
TR - Turchia 13
PL - Polonia 12
CZ - Repubblica Ceca 10
JP - Giappone 10
MA - Marocco 8
MX - Messico 8
NI - Nicaragua 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
EC - Ecuador 7
NL - Olanda 7
AU - Australia 6
EU - Europa 6
IQ - Iraq 6
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
PH - Filippine 5
AT - Austria 4
CR - Costa Rica 4
EG - Egitto 4
ET - Etiopia 4
KE - Kenya 4
LB - Libano 4
MY - Malesia 4
VE - Venezuela 4
CW - ???statistics.table.value.countryCode.CW??? 3
ES - Italia 3
GE - Georgia 3
GR - Grecia 3
ID - Indonesia 3
JM - Giamaica 3
JO - Giordania 3
MK - Macedonia 3
PY - Paraguay 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BO - Bolivia 2
BS - Bahamas 2
CH - Svizzera 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
KZ - Kazakistan 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 5.355
Città #
Chandler 298
Dublin 275
Jacksonville 215
San Jose 200
Singapore 196
Nanjing 178
Ashburn 168
Hong Kong 160
Beijing 131
Council Bluffs 114
Dallas 105
Boardman 78
Nanchang 70
Ann Arbor 59
Los Angeles 55
Johannesburg 54
Lawrence 50
Princeton 49
Wilmington 46
Hebei 45
Helsinki 43
Lauterbourg 43
Ho Chi Minh City 42
Jiaxing 40
Medford 40
New York 40
Shenyang 39
Changsha 38
Hanoi 33
Munich 30
Turku 29
Buffalo 25
Hangzhou 25
Moscow 24
Tianjin 24
Milan 22
Santa Clara 21
Shanghai 20
Brussels 14
Chennai 14
Des Moines 13
Seattle 13
Atlanta 12
Redondo Beach 12
Warsaw 12
Woodbridge 11
Da Nang 10
London 10
Guangzhou 9
San Francisco 9
Tokyo 9
Brno 8
Montreal 8
Norwalk 8
Orem 8
Brooklyn 7
Fairfield 7
Frankfurt am Main 7
Managua 7
São Paulo 7
The Dalles 7
Boston 6
Chicago 6
Houston 6
Kunming 6
Pavia 6
Stockholm 6
Tashkent 6
Verona 6
Haiphong 5
Quito 5
Santa Fe 5
St Petersburg 5
Stamford 5
The Bronx 5
Toronto 5
Addis Ababa 4
Amsterdam 4
Mexico City 4
Miami 4
Mumbai 4
Salt Lake City 4
Salvador 4
San Genesio Ed Uniti 4
Turin 4
Alexandria 3
Amman 3
Andover 3
Ankara 3
Belo Horizonte 3
Biên Hòa 3
Brasília 3
Calgary 3
Cambridge 3
Carapicuíba 3
Charlotte 3
Falkenstein 3
Fes 3
Fortaleza 3
Haikou 3
Totale 3.510
Nome #
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 167
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system 156
Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma 152
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 145
Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma. 142
Bortezomib-induced paralytic ileus is a potential gastrointestinal side-effect of this first-in-class anti-cancer proteasome inhibitor 133
[Idiopathic myelodysplastic syndromes. A caseload contribution]. 133
Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy 133
Tumor burden at diagnosis is the main clinical predictor of cell resistance in patients with early-stage, favorable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy. 132
New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. 130
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 130
International prognostic scoring system for Waldenstrom macroglobulinemia 127
Erratum to: Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study (Intern Emerg Med, (2014), 9, (861-870), DOI 10.1007/s11739-014-1096-1) 126
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 122
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. 119
The prognosis of patients with liver metastases from colorectal cancer still depends on anatomical presentation more than on treatments 119
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 118
Improving the AJCC/TNM Classification for use in early gastric cancer 118
Basic and acidic isoferritins in the serum of patients with Hodgkin's disease. 116
Prognostic validation of the international classification of immunoglobulin M gammopathies: A survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance? 116
Pamidronate versus observation in asymptomatic myeloma: final results with long follow-up of a randomized study 114
R-CHOP vs. R-mini-CEOP for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL). 114
Metabolic tumour volumes measured at staging in lymphoma: Methodological evaluation on phantom experiments and patients 113
How I treat enteropathy-associated T-cell lymphoma 111
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 110
International prognostic scoring system for Waldenstrom macroglobulinemia. 110
Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in- class anticancer proteasome inhibitor. 110
Long-term follow-up of Crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells 109
Changing clinical presentation of multiple myeloma. 108
Chronic granulocytic leukemia. A retrospective study of 91 cases. I. Hemogram at diagnosis and research of prognostic factors. 108
Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy. 105
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 103
Tumor burden in Hodgkin’s lymphoma: much more than the best prognostic factor. 101
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters 100
Hodgkin lymphoma. 100
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 98
What has happened to VBM (vinblastine, bleomycin and methotrexate) chemotherapy for early-stage Hodgkin lymphoma ? 96
Long-term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with ProMECE-CytaBOM plus involved-field radiation therapy: a study of the Gruppo Italiano Studio Linfomi. 95
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study 95
Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. 94
Long-term follow-up analysis of HD9601 trial comparing ABVD vs. Stanford V vs. MOPPEBVCAD in patients with newly diagnosed advanced-stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (IIL). 93
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial. 91
Prognostic factors in symptomatic Waldenstrom's macroglobulinemia 83
The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer 78
Reed-Sternberg cell leukaemia. 76
Natural history of idiopathic refractory sideroblastic anemia. 72
Low incidence but poor prognosis of complicated coeliac disease in four Italian centres. 69
Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility 68
Prognostic factors in non-Hodgkin's lymphomas 55
Totale 5.413
Categoria #
all - tutte 22.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022230 0 0 0 4 7 2 6 15 6 11 40 139
2022/2023790 76 76 9 67 81 76 2 56 316 6 16 9
2023/2024235 44 39 10 17 19 56 3 28 1 5 4 9
2024/2025682 33 51 20 16 25 19 39 32 178 19 80 170
2025/20261.661 100 82 166 200 221 60 321 99 147 143 53 69
2026/2027425 30 120 100 175 0 0 0 0 0 0 0 0
Totale 5.413